We are Sorry, This Page doesn't Exist
Veru announces presentation of Phase 2 clinical data of enobosarm
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Biosciences announces first patient dosed in Phase 3 SQ MarzAA study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rezolute announces study results from Phase 1a of RZ402
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novan announces final Week-12 visit for last patient in B-SIMPLE4 Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sarepta reports clinical results from Phase 2 MOMENTUM study of SRP-5051
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Galmed announces NMPA approved IND for Phase 3 ARMOR registrational study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Regulus announces results from Phase 1b clinical trial of RGLS4326
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Daxor announces new clinical study data on BVA-100 blood test
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aziyo Biologics announces initiation of De Novo CanGaroo clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
G1 Therapeutics announces initiation of Phase 3 study of COSELA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ampio announces results from AP-014 Phase I clinical trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex announces NaV1.8 inhibitor advancing to Phase 2 clinical development
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
uniQure announces removal of clinical hold on hemophiilia B gene therapy program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Onconova announces first patient dosed in phase 2 study of Rigosertib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MediWound announces enrollment of first patient in phase 2 study of EscharEx
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Yumanity Therapeutics announces data from Phase 1a MAD study of YTX-7739
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sorrento Therapeutics announces results of Phase 1b study of COVI-MSC treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vincerx Pharma announces FDA clearance of IND for Phase 1b study of VIP152
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Jazz Pharma announces results from Phase 3 study of XywavTM oral solution
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam announces full "positive" results from HELIOS-A Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»